相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative Molecular Life History of Spontaneous Canine and Human Gliomas
Samirkumar B. Amin et al.
CANCER CELL (2020)
Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma
Yang W. Shao et al.
ONCOGENE (2019)
Rituximab dosing in hematological malignancies: an old question, revisited
Peter N. Morcos et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
Anna Felberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Fast protein sequencing of monoclonal antibody by real-time digestion on emitter during nanoelectrospray
Yuan Mao et al.
MABS (2019)
A comparison of risk factors for metastasis at diagnosis in humans and dogs with osteosarcoma
Brandon J. Diessner et al.
CANCER MEDICINE (2019)
Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer
Alvaro H. Ingles Garces et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments
Glenn R. Masson et al.
NATURE METHODS (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Accurate Sequence Analysis of a Monoclonal Antibody by Top-Down and Middle-Down Orbitrap Mass Spectrometry Applying Multiple Ion Activation Techniques
Luca Fornelli et al.
ANALYTICAL CHEMISTRY (2018)
Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials
Judit Fazekas-Singer et al.
ONCOTARGET (2017)
Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry
Yuetian Yan et al.
ANALYTICAL CHEMISTRY (2016)
The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine
Saurabh Jain et al.
PLOS ONE (2016)
Canine and feline lymphoma: challenges and opportunities for creating a paradigm shift
D. J. Argyle et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2016)
Conformation-controlled binding kinetics of antibodies
Marta Galanti et al.
SCIENTIFIC REPORTS (2016)
Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model
Jennifer A. MacDiarmid et al.
PLOS ONE (2016)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential
Daisuke Ito et al.
LEUKEMIA & LYMPHOMA (2015)
Extended bottom-up proteomics with secreted aspartic protease Sap9
Uenige A. Laskay et al.
JOURNAL OF PROTEOMICS (2014)
Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 Protein
Thomas Kaever et al.
JOURNAL OF VIROLOGY (2014)
Generation of a Canine Anti-EGFR (ErbB-1) Antibody for Passive Immunotherapy in Dog Cancer Patients
Josef Singer et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients
Ashley A. Vo et al.
TRANSPLANTATION (2014)
Comparison of two functional kappa light-chain transcripts amplified from a hybridoma
Juan Yang et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2013)
One world, one health
Paul D. van Helden et al.
EMBO REPORTS (2013)
Rituximab biosimilars
Edward M. Vital et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Rituximab in the treatment of non-Hodgkin's lymphoma - a critical evaluation of randomized controlled trials
Morag Meriel Griffin et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Rituximab therapy in nephrotic syndrome: implications for patients' management
Aditi Sinha et al.
NATURE REVIEWS NEPHROLOGY (2013)
Comparative Gene Expression Profiling Identifies Common Molecular Signatures of NF-κB Activation in Canine and Human Diffuse Large B Cell Lymphoma (DLBCL)
Manikhandan A. V. Mudaliar et al.
PLOS ONE (2013)
Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review
Tamara Castillo-Trivino et al.
PLOS ONE (2013)
Ipilimumab (Yervoy) and the TGN1412 catastrophe
Tibor Bakacs et al.
IMMUNOBIOLOGY (2012)
Authentication of Primordial Characteristics of the CLBL-1 Cell Line Prove the Integrity of a Canine B-Cell Lymphoma in a Murine In Vivo Model
Barbara C. Ruetgen et al.
PLOS ONE (2012)
Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective
Pashtoon M. Kasi et al.
CRITICAL CARE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
MSTools-Web based application for visualization and presentation of HXMS data
Daniel Kavan et al.
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY (2011)
Urbanisation and infectious diseases in a globalised world
Emilie Alirol et al.
LANCET INFECTIOUS DISEASES (2011)
Clinical radioimmunotherapy-the role of radiobiology
Jean-Pierre Pouget et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Monoclonal antibodies and fusion proteins and their complications: Targeting B cells in autoimmune diseases
Susan Lee et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Therapeutic (High) Doses of Rituximab Activate Calcium Mobilization and Inhibit B-cell Growth via an Unusual Mechanism Triggered Independently of Both CD20 and Fc gamma Receptors
Tammy L. Unruh et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody
Boyan Zhang et al.
ANALYTICAL CHEMISTRY (2008)
The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20
Jessica L. Teeling et al.
JOURNAL OF IMMUNOLOGY (2006)
The dog as a cancer model
Chand Khanna et al.
NATURE BIOTECHNOLOGY (2006)
Isolation and characterization of the B-cell marker CD20
JA Ernst et al.
BIOCHEMISTRY (2005)
CD20: A target antigen for immunotherapy of autoimmune diseases
F Perosa et al.
AUTOIMMUNITY REVIEWS (2005)
Anti-B cell therapy (Rituximab) in the treatment of autoimmune diseases
SA Chambers et al.
LUPUS (2005)
Antibody dependent cell mediated cytotoxicity and phagocytosis of senescent erythrocytes by autologous peripheral blood mononuclear cells
P Berkman et al.
AUTOIMMUNITY (2002)
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia:: a phase II multicenter trial
GA Wiseman et al.
BLOOD (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cloning and characterization of cDNAs encoding four different canine immunoglobulin γ chains
L Tang et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2001)
分享论文
